메뉴 건너뛰기
The Lancet Oncology
Volumn 10, Issue 3, 2009, Pages 201-202
Predicting the future in castration-resistant prostate cancer
Author keywords

[No Author keywords available]
Indexed keywords

ALBUMIN; HEMOGLOBIN; LACTATE DEHYDROGENASE; PROSTATE SPECIFIC ANTIGEN;
EID: 62849092810     PISSN: 14702045     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1470-2045(09)70049-X     Document Type: Letter
Times cited : (2)
References (5)
  • 1
    • 0036789479 scopus 로고    scopus 로고
    • Nomogram for overall survival of patients with progressive metastatic prostate cancer after castration
    • Smaletz O., Scher H.I., Small E.J., et al. Nomogram for overall survival of patients with progressive metastatic prostate cancer after castration. J Clin Oncol 20 (2002) 3972-3982
    • (2002) J Clin Oncol , vol.20 , pp. 3972-3982
    • Smaletz, O.1    Scher, H.I.2    Small, E.J.3
  • 2
    • 33745234831 scopus 로고    scopus 로고
    • Prostate-specific antigen (PSA) alone is not an appropriate surrogate marker of long-term therapeutic benefit in prostate cancer trials
    • Collette L., Burzykowski T., and Schroder F.H. Prostate-specific antigen (PSA) alone is not an appropriate surrogate marker of long-term therapeutic benefit in prostate cancer trials. Eur J Cancer 42 (2006) 1344-1350
    • (2006) Eur J Cancer , vol.42 , pp. 1344-1350
    • Collette, L.1    Burzykowski, T.2    Schroder, F.H.3
  • 3
    • 62849099048 scopus 로고    scopus 로고
    • Circulating tumour cells as prognostic markers in progressive, castration-resistant prostate cancer: a reanalysis of IMMC38 trial data
    • Scher H.I., Jia X., de Bono J.S., et al. Circulating tumour cells as prognostic markers in progressive, castration-resistant prostate cancer: a reanalysis of IMMC38 trial data. Lancet Oncol 10 (2009) 233-239
    • (2009) Lancet Oncol , vol.10 , pp. 233-239
    • Scher, H.I.1    Jia, X.2    de Bono, J.S.3
  • 4
    • 58149165081 scopus 로고    scopus 로고
    • Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer
    • de Bono J.S., Scher H.I., Montgomery R.B., et al. Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer. Clin Cancer Res 14 (2008) 6302-6309
    • (2008) Clin Cancer Res , vol.14 , pp. 6302-6309
    • de Bono, J.S.1    Scher, H.I.2    Montgomery, R.B.3
  • 5
    • 33749497739 scopus 로고    scopus 로고
    • Asynchronous growth of prostate cancer is reflected by circulating tumor cells delivered from distinct, even small foci, harboring loss of heterozygosity of the PTEN gene
    • Schmidt H., DeAngelis G., Eltze E., Gockel I., Semjonow A., and Brandt B. Asynchronous growth of prostate cancer is reflected by circulating tumor cells delivered from distinct, even small foci, harboring loss of heterozygosity of the PTEN gene. Cancer Res 66 (2006) 8959-8965
    • (2006) Cancer Res , vol.66 , pp. 8959-8965
    • Schmidt, H.1    DeAngelis, G.2    Eltze, E.3    Gockel, I.4    Semjonow, A.5    Brandt, B.6

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.